Tuesday, November 17, 2026
Science
No Result
View All Result
  • Login
  • HOME
  • SCIENCE NEWS
  • CONTACT US
  • HOME
  • SCIENCE NEWS
  • CONTACT US
No Result
View All Result
Scienmag
No Result
View All Result
Home Science News Cancer

AlphaFold3 predicts T cell receptor antigen specificity from sequence alone

November 12, 2026
in Cancer, Medicine
Nathaniel Bowman
By Nathaniel Bowman Scienmag Editorial Profile - Precision Oncology
Reading Time: 4 mins read
0
AlphaFold3 predicts T cell receptor antigen specificity from sequence alone

AlphaFold3 predicts T cell receptor antigen specificity from sequence alone

65
SHARES
587
VIEWS
Share on FacebookShare on Twitter
ADVERTISEMENT

Scientists at the Translational Genomics Research Institute, part of City of Hope, have shown that the artificial intelligence platform AlphaFold3 can predict whether a T cell receptor will recognize a specific antigen based solely on genetic sequence.

The recognition process at the heart of adaptive immunity depends on a three-part molecular complex. A display molecule called MHC grabs a fragment of a virus, bacterium, or tumor cell and holds it out for inspection. A T cell then checks that fragment with its receptor, the TCR. If the receptor fits the MHC molecule and its peptide cargo just right, the T cell registers the encounter as a threat and launches an attack aimed at it. Scientists call this triad the MHC:peptide:TCR complex, a set of three molecules that only work as a team, and it is one of the main ways the immune system recognizes what it needs to fight.

The unique structure of each T cell receptor enables the immune system to distinguish among billions of potential antigens. While researchers have experimentally determined the structures of some TCRs and the antigens they recognize, many others are known only through their genetic sequences. Predicting whether a given receptor would recognize an arbitrary antigen has therefore remained a significant challenge. John Altin, Ph.D., an associate professor in TGen’s Immunology and Microbiome Division and a senior author of the study, described the state of the field bluntly: before this work, if you knew nothing about the target antigen and wanted to know whether a TCR sequence was specific to it, the best you could do was a random guess.

AlphaFold transformed structural biology by enabling researchers to predict three-dimensional molecular structures from genetic sequences. The third version of the platform, introduced in 2024, was designed specifically to predict interactions among multiple molecules, which makes it particularly well suited for modeling MHC:peptide:TCR complexes.

To evaluate the platform’s performance, the TGen team first tested AlphaFold3 using triads whose structures had already been determined experimentally. After confirming its accuracy on these known cases, the researchers analyzed a larger group of immune complexes to identify structural features associated with T cell recognition and non-recognition of specific antigens.

The investigators then challenged the model using high-quality genetic sequences from previously uncharacterized immune complexes, including eight MHC class II-antigen pairs derived from the bacterium that causes tuberculosis. Tuberculosis presented an especially rigorous test because the pathogen contains numerous antigens, while the MHC molecules responsible for presenting those antigens vary significantly among individuals and populations worldwide. It is also a disease where new vaccines and diagnostics are sorely needed. The researchers found that AlphaFold3 was able to model these immune complexes with sufficient accuracy to predict whether a T cell receptor would recognize antigens known only from their genetic sequences.

“Now we can do clearly better than chance,” Altin said. “It’s remarkable that a general structural model like AlphaFold 3 works on such a specialized task, and we expect it to improve from here.” The antigens examined in the tuberculosis work, he noted, fall within large unexplored or underexplored regions of the antigen space, something the team is very interested in. The study demonstrates how AlphaFold3 can accurately model the complex three-part molecular interaction that lies at the center of the body’s adaptive immune response, and by revealing how these molecules fit together, the approach may help researchers better predict which immune cells can recognize and respond to specific pathogens or cancer targets.

If further validated, the approach could help accelerate research into infectious diseases, cancer immunotherapy and vaccine development by enabling scientists to identify promising immune targets more efficiently. By helping researchers better understand how immune cells recognize threats, the technology may provide a powerful new tool for studying the immune responses that protect the body from disease.

The researchers have been working simultaneously on a second triad challenge, said Kamel Lahouel, Ph.D., an assistant professor in TGen’s Early Detection and Prevention Division and co-author of the study. “We have also been very interested in the particular step that comes before the TCR gets involved, which is how to predict the binding affinity between the peptide and an MHC class II molecule,” Lahouel said. In a joint effort across TGen research groups involving teams led by Lahouel, Altin, and Cristian Tomasetti, Ph.D., the researchers are building on AlphaFold3’s structural modeling with downstream graph-based neural networks, trained using data on hundreds of thousands of peptide interactions from Altin’s PepSeq assays, to develop a predictor of MHC class II-peptide binding affinity.

The research was supported by the National Institutes of Health through grants R21AI149311, R01AI173002, and 75N93024C00054. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The study, titled “General prediction of T cell receptor antigen specificity from sequence using AlphaFold 3,” was published in Science Advances on 30 October 2026, and was classified as computational simulation and modeling research with cells as its subject of investigation.

Subject of Research: Prediction of T cell receptor antigen specificity from sequence using the AI platform AlphaFold3

Article Title: TGen scientists use AlphaFold3 to predict complex immune interactions

Article References: TGen scientists use AlphaFold3 to predict complex immune interactions. Original publication (Bibliographic details unavailable.)

Image Credits: AI Generated

DOI: Not provided

Keywords: AlphaFold3, TGen, T cell receptor, antigen specificity, MHC:peptide:TCR complex, tuberculosis, immunology, Science Advances, AI structural biology, cancer immunotherapy, vaccine development, peptide-MHC binding

Cite Scienmag News

Nathaniel Bowman. (November 12, 2026). AlphaFold3 predicts T cell receptor antigen specificity from sequence alone. Scienmag. https://scienmag.com/alphafold3-predicts-t-cell-receptor-antigen-specificity-from-sequence-alone/

Nathaniel Bowman. "AlphaFold3 predicts T cell receptor antigen specificity from sequence alone." Scienmag, 12 November 2026, https://scienmag.com/alphafold3-predicts-t-cell-receptor-antigen-specificity-from-sequence-alone/. Accessed 17 November 2026.

Nathaniel Bowman. "AlphaFold3 predicts T cell receptor antigen specificity from sequence alone." Scienmag. November 12, 2026. https://scienmag.com/alphafold3-predicts-t-cell-receptor-antigen-specificity-from-sequence-alone/

Tags: AI structural biologyAlphaFold3antigen specificitycancer immunotherapyimmunologyMHC:peptide:TCR complexpeptide-MHC bindingScience AdvancesT cell receptorTGentuberculosisVaccine development
Share26Tweet16
Previous Post

Review Evaluates Next-Generation Sequencing for Precision Treatment in Ovarian Cancer

Next Post

Staphylococcus Bacteria Predominate in Adult Chronic Dacryocystitis Meta-Analysis

Related Posts

Industrial Co-Exposure to Aluminum and Hydrocarbons Linked to Worker Anxiety
Medicine

Industrial Co-Exposure to Aluminum and Hydrocarbons Linked to Worker Anxiety

November 17, 2026
MicroRNA Axis Correlates with Diabetic Foot Ulcer Severity in Clinical Study
Medicine

MicroRNA Axis Correlates with Diabetic Foot Ulcer Severity in Clinical Study

November 17, 2026
Ugandan Hospital Cohort Identifies Key Predictors and High Mortality of Neonatal Enterocolitis
Medicine

Ugandan Hospital Cohort Identifies Key Predictors and High Mortality of Neonatal Enterocolitis

November 17, 2026
Psychosocial Work Demands Drive Substantial Presenteeism Costs for Municipal Employers
Medicine

Psychosocial Work Demands Drive Substantial Presenteeism Costs for Municipal Employers

November 17, 2026
Ethiopian Children With Neurodevelopmental Disabilities Face Intersecting Barriers, Scoping Review Finds
Medicine

Ethiopian Children With Neurodevelopmental Disabilities Face Intersecting Barriers, Scoping Review Finds

November 17, 2026
Crushed Tadalafil Formulation Remains Physicochemically Stable for Ninety Days in Storage
Medicine

Crushed Tadalafil Formulation Remains Physicochemically Stable for Ninety Days in Storage

November 17, 2026
Next Post
Staphylococcus Bacteria Predominate in Adult Chronic Dacryocystitis Meta-Analysis

Staphylococcus Bacteria Predominate in Adult Chronic Dacryocystitis Meta-Analysis

  • Mothers who receive childcare support from maternal grandparents show more optimized

    Mothers who receive childcare support from maternal grandparents show more parental warmth, finds NTU Singapore study

    27656 shares
    Share 11059 Tweet 6912
  • University of Seville Breaks 120-Year-Old Mystery, Revises a Key Einstein Concept

    1061 shares
    Share 424 Tweet 265
  • Bee body mass, pathogens and local climate influence heat tolerance

    682 shares
    Share 273 Tweet 171
  • Researchers record first-ever images and data of a shark experiencing a boat strike

    546 shares
    Share 218 Tweet 137
  • Groundbreaking Clinical Trial Reveals Lubiprostone Enhances Kidney Function

    531 shares
    Share 212 Tweet 133
Science

Embark on a thrilling journey of discovery with Scienmag.com—your ultimate source for cutting-edge breakthroughs. Immerse yourself in a world where curiosity knows no limits and tomorrow’s possibilities become today’s reality!

RECENT NEWS

  • TCAD Simulations Identify Efficiency Gains for Sustainable CZTS Solar Cells
  • Engineered E. coli Secretes Thermophilic Cellulase Cocktail for Seawater-Compatible Biorefining
  • Editorial Analyzes Small Business Resilience Under Structural Market Turbulence
  • Industrial Co-Exposure to Aluminum and Hydrocarbons Linked to Worker Anxiety

Categories

  • Agriculture
  • Anthropology
  • Archaeology
  • Athmospheric
  • Biology
  • Biotechnology
  • Blog
  • Bussines
  • Cancer
  • Chemistry
  • Climate
  • Earth Science
  • Editorial Policy
  • Marine
  • Mathematics
  • Medicine
  • Pediatry
  • Policy
  • Psychology & Psychiatry
  • Science Education
  • Science News
  • Social Science
  • Space
  • Technology and Engineering

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 5,150 other subscribers

© 2026 Scienmag - Science Magazine

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In
No Result
View All Result
  • HOME
  • SCIENCE NEWS
  • CONTACT US

© 2026 Scienmag - Science Magazine

Discover more from Science

Subscribe now to keep reading and get access to the full archive.

Continue reading